Exchange: NYSE·Updated 07:34 PM EDT
News
all
press releases
Wall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High?
The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
More News
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
PACS Group, Inc. (PACS) Surpasses Q2 Earnings and Revenue Estimates
PACS Group, Inc. (PACS) delivered earnings and revenue surprises of +14.55% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
PACS Group, Inc. Reports Second Quarter 2026 Results
PACS Group, Inc. (NYSE: PACS) (PACS or the Company), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2026. Second Quarter 2026 Financial Highlights Revenue was $1.43 billion, an...
Business Wire
PACS or ALHC: Which Is the Better Value Stock Right Now?
PACS vs. ALHC: Which Stock Is the Better Value Option?
Zacks
PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
PACS Group, Inc. (NYSE: PACS) (PACS or the Company) announced today that it intends to report its financial results for the second quarter ended June 30, 2026, on Tuesday, August 4, 2026, after the stock market closes. Management will host a call on Wednesday, August 5, 2026, at 11:30 a.m. ET to...
Business Wire
Kaskela Law Firm Announces Investigation of PACS Group, Inc. (PACS) and Encourages Long-Term PACS Shareholders to Contact the Firm
Investor litigation firm Kaskela Law announces that it is investigating PACS Group, Inc. (NYSE: PACS) (PACS) on behalf of the companys long-term investors. Click here for additional information: https://kaskelalaw.com/case/pacs-group/ Recently a federal securities fraud complaint was filed against...
Business Wire
PACS or ALHC: Which Is the Better Value Stock Right Now?
PACS vs. ALHC: Which Stock Is the Better Value Option?
Zacks
NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit
NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit PR Newswire SAN DIEGO, July...
PR Newswire
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks

Advertisement|Remove ads.